Search - tctmd.com

Displaying 1 - 20 of 51

Sort: Relevancy | Date

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Conference News AHA 2017

More Support for TMVR After Failed Mitral Bioprostheses

Yael L. Maxwell

November 23, 2017

News Opinion Editor's Corner TCT 2017

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Shelley Wood

November 22, 2017

News Conference News TCT 2017

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

Todd Neale

November 09, 2017

News Conference News TCT 2017

A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients

Todd Neale

November 08, 2017

Presentation TCT 2017

Hemodynamic Trends on Serial Echocardiograms after TAVR: Comprehensive 5-Year Analyses From PARTNER

Presenter: Pamela S. Douglas

November 01, 2017

News Conference News TCT 2017

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Yael L. Maxwell

October 31, 2017

Presentation TCT 2017

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

Presenter: Peter C. Block, Lars Sondergaard, Tarun Chakravarty, MD

October 31, 2017

Presentation TCT 2017

Important Clinical Lessons From the VIVID Registry and the PARTNER Experience

Presenter: John G. Webb

October 30, 2017

Presentation TCT 2017

The PARTNER 3 Low-risk Trial

Presenter: Michael J. Mack

October 30, 2017

Presentation TCT 2017

Viewpoint #1: PARTNER 2A and SURTAVI are Convincing TAVR is Preferred in ALL (Appropriate) Intermediate-Risk Patients

Presenter: Michael J. Reardon

October 30, 2017

News Opinion Off Script TCT 2017

Off Script: Welcome to TCT 2017 in the Mile High City

Kwan S. Lee

October 29, 2017

Presentation TCT 2017

Case Presentation 6: BTK Intervention

Presenter: Sergey A. Abugov, Juan F. Granada, Zaza Kavteladze

October 29, 2017

Presentation TCT 2017

Editorial Comment

Presenter: Sergey A. Abugov, Juan F. Granada, Susheel K. Kodali

October 29, 2017

Presentation TCT 2017

Case Presentation 5: TAVR

Presenter: Sergey A. Abugov, Juan F. Granada, Alexey Protopopov

October 29, 2017

Presentation TCT 2017

Tricuspid Valve Interventions: Patient Selection, Devices, and Predictions

Presenter: Antonio Colombo, Samir R. Kapadia, Azeem Latib

October 29, 2017

Presentation TCT 2017

Troubleshooting During Left Atrial Appendage Closure

Presenter: Helene Eltchaninoff, Afzalur Rahman, Rabin dra Nath Chakraborty

October 29, 2017

Presentation TCT 2017

Clinical Case #2: A TAVR Procedure You Dont See Everyday

Presenter: Alejandro Cherro, Alfredo E. Rodriguez, Daniel H. Berrocal

October 29, 2017

Presentation TCT 2017

Mitral Valve Interventions: MitraClip, Annular Treatments, and Valves Where Will We Be in 5 Years? In 10 Years?

Presenter: Antonio Colombo, Azeem Latib, Jason H. Rogers

October 29, 2017

Presentation TCT 2017

Live in the Box: Complex TAVR Cases Made Simple

Presenter: Helene Eltchaninoff, Afzalur Rahman

October 29, 2017

Advertisement

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

More Support for TMVR After Failed Mitral Bioprostheses

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients

Hemodynamic Trends on Serial Echocardiograms after TAVR: Comprehensive 5-Year Analyses From PARTNER

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

Important Clinical Lessons From the VIVID Registry and the PARTNER Experience

The PARTNER 3 Low-risk Trial

Viewpoint #1: PARTNER 2A and SURTAVI are Convincing TAVR is Preferred in ALL (Appropriate) Intermediate-Risk Patients

Off Script: Welcome to TCT 2017 in the Mile High City

Case Presentation 6: BTK Intervention

Editorial Comment

Case Presentation 5: TAVR

Tricuspid Valve Interventions: Patient Selection, Devices, and Predictions

Troubleshooting During Left Atrial Appendage Closure

Clinical Case #2: A TAVR Procedure You Dont See Everyday

Mitral Valve Interventions: MitraClip, Annular Treatments, and Valves Where Will We Be in 5 Years? In 10 Years?

Live in the Box: Complex TAVR Cases Made Simple

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content